Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

BUY
$8.32 - $15.45 $1.25 Million - $2.32 Million
150,000 Added 250.0%
210,000 $1.83 Million
Q4 2023

Feb 14, 2024

BUY
$8.79 - $11.51 $527,400 - $690,600
60,000 New
60,000 $686,000
Q4 2021

Feb 11, 2022

SELL
$10.86 - $13.95 $434,400 - $558,000
-40,000 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$11.92 - $13.92 $1.23 Million - $1.43 Million
-102,800 Reduced 71.99%
40,000 $522,000
Q1 2021

May 17, 2021

BUY
$9.04 - $11.86 $974,511 - $1.28 Million
107,800 Added 308.0%
142,800 $1.6 Million
Q3 2019

Nov 14, 2019

BUY
$8.59 - $10.96 $300,650 - $383,600
35,000 New
35,000 $301,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.